Skip to main content
. 2022 Sep 20;12:912016. doi: 10.3389/fonc.2022.912016

Table 1.

Comparisons of parameters between patients with colorectal cancer and liver and non-liver metastases.

Parameter Non-Liver metastases N= 259 (means ± SEM) or (%) Liver metastases N= 97 (means ± SEM) or (%)
Age 58.38 ± 0.79  56.93 ± 1.17  
FR-CTC 10.26 ± 0.12 **** 13.38 ± 0.35 ****
HSP90 51.16 ± 2.87 **** 78.19 ± 6.10 ****
CEA 39.79 ± 9.69 * 84.59 ± 26.70 *
CA199 41.09 ± 9.55 *** 126.10 ± 28.33 ***
KI67 69.81 ± 0.85 72.90 ± 1.39
P53 55.86 ± 1.16 52.21 ± 2.45
Tumor diameter 4.37 ± 0.11 4.80 ± 0.19
Number of lymph node metastases 1 ± 0.16 **** 3± 0.42****
Gender 
 Male 104 (40.15) 58 (59.79)
 Female 155 (59.85) 39 (40.21)
CK7
 Positive 15 (5.79) 8 (8.25)
 Negative 244 (94.21) 89 (91.75)
CK20
 Positive 86 (33.20) 28 (28.87)
 Negative 173 (66.80) 69 (71.13)
Villin
 Positive 70 (27.03) 27 (27.84)
 Negative 189 (72.97) 70 (72.16)
β-catenin
 Positive 63 (24.32) 14 (14.43)
 Negative 196 (75.68) 83 (85.57)
S100
 Positive 55 (21.24) 16 (16.50)
 Negative 204 (78.76) 81 (83.50)
Location of primary tumor
 Colon 123(47.49) 56 (57.73)
 Rectal 136 (52.51) 41 (42.27)
Differentiation type
 Well differentiation 18 (6.95) 3 (3.09)
 Moderately differentiation 233(89.96) 88 (90.72)
 Poorly differentiation 8 (3.09) 6 (6.19)

*p > 0.05 between liver metastases and non-liver metastases.

***p > 0.001 between liver metastases and non-liver metastases.

****p > 0.0001 between liver metastases and non-liver metastases.